AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2017
Feb 13, 2017
30237_dirs_2017-02-13_caa2d4fa-9f4b-454e-85f8-657275d24516.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-02-09
Reporting Person: Dodson Edward T (Principal Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-09 | Common Stock | M | 450 | — | Acquired | 3367.5849 | Direct |
| 2017-02-09 | Common Stock | F | 138 | $133.83 | Disposed | 3229.5849 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-09 | Restricted Stock Unit | $ | M | 450 | Disposed | Common Stock (450) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Amount includes 155.1793 shares acquired on June 30, 2016 under the Laboratory Corporation of America Holdings 1997 Employee Stock Purchase Plan and 45.841 shares acquired on December 31, 2016 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3: Stock withholding to satisfy tax withholding obligations.
F4: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17.
F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.